When is the long-term toxicity of cancer treatment too great, and what can be done? Associate Professor Rachel Conyers is part of a team providing the answers.
Up until two years ago, seriously ill Tasmanian children like Macy were forced to travel to the mainland to take part in clinical trials. Then Associate Professor John Heath decided enough was enough.
After more than a decade of research, this senior paediatric oncologist is closing in on innovative tumour treatment that stands to help kids with leukaemia too.